Skip to Main Content

Paper Details

Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations.
Addict Sci Clin Pract
2
2023
CTN-0051 X, CTN-0067, MOUD, NTX, OUD, XR-NTX, amphetamines, buprenorphine, cocaine, depression, methamphetamine, naltrexone, opioid use disorder, participants, patients, people
Author NameAffiliation
Onyebuchi A ArahFielding School of Public Health, University of California, Los Angeles (university of california los angeles)
Onyebuchi A Arahuniversity of california los angeles College
Onyebuchi A ArahResearch Unit for Epidemiology, Aarhus University
Onyebuchi A ArahFielding School of Public Health, University of California, Los Angeles (university of california los angeles)
Onyebuchi A Arahuniversity of california los angeles College
Onyebuchi A ArahResearch Unit for Epidemiology, Aarhus University
Philip Todd KorthuisOregon Health & Science University
  • 1 - 7

Datasets

Release 1.2